Articles related to CIRCULATING TUMOR DNA
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
The researchers tested whether a ctDNA-guided strategy could lower the need for adjuvant chemotherapy without increasing the risk of recurrence. Recurrence-free survival at 2 years was the main efficacy end objective. Adjuvant chemotherapy usage was a significant secondary end goal.
Oncology, Medical January 9th 2023
The Role of Circulating Tumor DNA in Evaluating Minimal Residual Disease in Luminal Gastrointestinal Malignancies
ctDNA provides an intriguing, noninvasive means of evaluating solid organ malignancies—from early diagnosis to personalized treatment decisions to prognosis and estimating risk of recurrence.
Oncology, Medical July 25th 2022